202 Efficacy and Safety of Icotrokinra, a Novel Targeted Oral Peptide, in Adolescents With Moderate-to-Severe Plaque Psoriasis: Subgroup Analyses From the Phase 3 ICONIC-LEAD Study
1. 系统已在2025-12-21 21:09:07对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.jid.2025.09.207
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0022202X25026673
其他信息:
出版社: Elsevier BV
作者: Lawrence Eichenfield; Ricardo Galimberti; Adelaide Hebert; Wenhui Wang; Jennifer Soung; Nina Magnolo; John Browning; Angela Moore; Mark Lebwohl; Dagmar Wilsmann-Theis; Joseph F. Merola; Georgios Kokolakis; Dariusch Mortazawi; Parbeer Grewal; Megan Miller; Joseph Cafone; Shu Li; Gig Jiang; Fabio Nunes; Cynthia DeKlotz; Amy Paller

